Patents Assigned to BIOTHERA PHARMACEUTICALS, INC.
  • Yeast cell wall enriched in mannan oligosaccharide protein
    Patent number: 10582723
    Abstract: The present invention relates to yeast cell wall 5 compositions enriched with mannose, mannose extracts and processes for making the same.
    Type: Grant
    Filed: April 14, 2015
    Date of Patent: March 10, 2020
    Assignee: Biothera Pharmaceuticals, Inc.
    Inventors: Donald J. Cox, Michael Danielson, Kyle S. Michel
  • BETA GLUCAN IMMUNOPHARMACODYNAMICS
    Publication number: 20200033362
    Abstract: This disclosure provides, in one aspect, dosing strategies for soluble ?-glucan immunotherapy to optimize acute immunopharmacodynamic responses for the immunotherapy and/or subject. It also provides a method for analyzing a sample from a subject for a biomarker to identify the appropriate dosing strategy for soluble ?-glucan immunotherapy. Generally, the method includes obtaining a biological sample from a subject, analyzing the sample for a biomarker anti-?-glucan antibody level or immunopharmacodynamic response level, classifying the subject into a subgroup based on the biomarker anti-?-glucan antibody level or immunopharmacodynamic response level and identifying the appropriate dosing strategy based on the subgroup classification.
    Type: Application
    Filed: February 23, 2018
    Publication date: January 30, 2020
    Applicant: BIOTHERA PHARMACEUTICALS, INC.
    Inventors: Nandita BOSE, Nadine OTTOSON, Ben HARRISON, Jamie LOWE, Mark UHLIK, Jeremy GRAFF, Richard HUHN